JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and David Austin, MD, FRCP discuss PROACT, a phase three randomized open label blinded endpoint superiority trial of enalapril to prevent anthracycline induced cardiotoxicity.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
